TROW
47
-6
NOV
52
-5
WM
74
-5
HSIC
45
5
SNA
70
-5
CPB
22
-5
CMI
64
-3
SEE
53
3
GILD
47
-8
ORLY
60
-5
OI
42
-3
MAS
52
-4
WMB
68
2
SPG
60
2
SYY
49
9
GOOGL
48
-5
SBUX
37
-2
PSA
56
3
PDCO
29
2
NSC
53
-4
TROW
47
-6
NOV
52
-5
WM
74
-5
HSIC
45
5
SNA
70
-5
CPB
22
-5
CMI
64
-3
SEE
53
3
GILD
47
-8
ORLY
60
-5
OI
42
-3
MAS
52
-4
WMB
68
2
SPG
60
2
SYY
49
9
GOOGL
48
-5
SBUX
37
-2
PSA
56
3
PDCO
29
2
NSC
53
-4
Financhill
Back

PIMCO Corporate & Income Opportunity Fds Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
49

PTY
PIMCO Corporate & Income Opportunity Fds

Last Price:
14.51
Seasonality Move:
3.38%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
49
PIMCO Corporate & Income Opportunity Fds (PTY) is a Sell

Is PIMCO Corporate & Income Opportunity Fds a Buy, Sell or Hold?

  • The current PIMCO Corporate & Income Opportunity Fds [PTY] share price is $14.51. The Score for PTY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • PTY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTY Stock Price Chart

What is PIMCO Corporate & Income Opportunity Fds's stock price today?

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

PTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 47.2 Sell
Chaikin Money Flow: 123500 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.46 - 14.62) Sell
Bollinger Bands (100): (14.23 - 14.51) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

PTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.6 Sell
20-day SMA: 14.56 Sell
50-day SMA: 14.46 Buy
200-day SMA: 14.34 Buy
8-day EMA: 14.56 Sell
20-day EMA: 14.55 Sell
50-day EMA: 14.48 Buy
200-day EMA: 14.25 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

PIMCO Corporate & Income Opportunity Fds Earnings Growth & PTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

PIMCO Corporate & Income Opportunity Fds Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):